levofloxacin has been researched along with Neutropenia in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.44) | 18.2507 |
| 2000's | 25 (60.98) | 29.6817 |
| 2010's | 12 (29.27) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, K; Ishida, H; Ishida, Y; Kawato, H; Kurosaka, Y; Lee, VJ; Nakayama, K; Ohta, T; Ohtsuka, M; Otani, T; Renau, TE; Watkins, WJ; Yokomizo, Y; Yoshida, K | 1 |
| Deziel, MR; Drusano, GL; Liu, W; Louie, A | 1 |
| Achorn, C; Chen, CL; Clark, RB; Deng, Y; Fyfe, C; Grossman, TH; He, M; Hogan, PC; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sutcliffe, JA; Xiao, XY; Zhu, Z | 1 |
| Assanelli, AA; Bernardi, M; Carletti, S; Carrabba, MG; Castagna, A; Ciceri, F; Clerici, D; Corti, C; Erbella, F; Farina, F; Galli, L; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Lugli, AP; Lupo Stanghellini, MT; Mancini, N; Mastaglio, S; Nitti, R; Oltolini, C; Peccatori, J; Poli, A; Ripa, M; Ruggeri, A; Scarpellini, P; Tassan Din, C; Xue, E | 1 |
| Chinen, S; Ishizu, M; Mogi, A; Nakashima, Y; Sasaki, H; Takamatsu, Y; Takata, T; Tanaka, T | 1 |
| Araoka, H; Asano-Mori, Y; Ishiwata, K; Kageyama, K; Kaji, D; Kimura, M; Mitsuki, T; Nishida, A; Ogura, S; Takagi, S; Taniguchi, S; Taya, Y; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yuasa, M | 1 |
| Przybylski, DJ; Reeves, DJ | 1 |
| Flynn, PM; Gaur, AH; Hakim, H; Hayden, RT; Inaba, H; Jeha, S; Pui, CH; Stewart, T; Sun, Y; Tang, L; Wolf, J | 1 |
| Knoebel, RW; Lee, P; Pettit, NN; Pisano, J | 1 |
| Baker, TM; Chavda, KD; Chen, L; Fowler, VG; Jacobs, SE; Jenkins, SG; Kreiswirth, BN; Satlin, MJ; Schuetz, AN; Shashkina, E; Shore, TB; Small, CB; Soave, R; van Besien, K; Walsh, TJ; Westblade, LF | 1 |
| Audisio, E; Busca, A; De Rosa, FG; Di Perri, G; Frairia, C; Marmont, F; Motta, I | 1 |
| Alonso, JM; Cantón, R; Cuartero, C; Del Campo, R; López, J; Lozano, S; Rodríguez, JD; Rodríguez-Domínguez, M; Ruiz-Garbajosa, P; Sánchez-Díaz, AM; Tedim, AP | 1 |
| Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Park, GE; Peck, KR; Seok, HR; Song, JH | 1 |
| Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Machishima, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R | 1 |
| Petrosillo, N | 1 |
| Bellesso, M; Chamone, D; Costa, SF; Dorlhiac-Llacer, PE; Pracchia, LF; Santos Dias, LC | 1 |
| Khan, MA; Rahman, MM | 1 |
| Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V | 1 |
| Deuss, B; Dickgreber, N; Nagel, S; Pabst, S; Roscher, K; Salm, T; Schuette, W; Schumann, C; von Weikersthal, LF | 1 |
| Catamo, G; D'Antonio, D; D'Ercole, S; Di Bonaventura, G; Piccolomini, R | 1 |
| Alvarez Corral, G; Clavero Farré, C; García Pérez, MJ; Giménez Garrido, F; Gracia Escudero, A; Martín González, M; Reyes Bertos, A; Rodríguez Cuartero, A; Villegas Maldonado, G | 1 |
| Dijstelbloem, Y; Huijgens, PC; Simoons-Smit, AM; Timmers, GJ; Touw, DJ; van Winkelhoff, AJ; Vandenbroucke-Grauls, CM | 1 |
| Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T | 1 |
| Elliott, MA; Patel, R; Prabhu, RM | 1 |
| Al-Khadimi, Z; Chow, WA; Doroshow, JH; Frankel, P; Lawrence, J; Leong, L; Lim, D; Longmate, J; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Twardowski, P; Yen, Y | 1 |
| Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
| Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H | 1 |
| Allione, B; Amadori, S; Bucaneve, G; Buelli, M; Cantaffa, R; Cilloni, D; D'Antonio, D; Del Favero, A; Deliliers, GL; Dionisi, MS; Fabbiano, F; Foà, R; Lauria, F; Martinelli, G; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Specchia, G; Zuffa, E | 1 |
| Billingham, L; Bower, M; Cullen, M; Fernando, I; Gaunt, C; Gollins, S; Hastings, M; Huddart, R; Rea, D; Simmonds, P; Stanley, A; Steven, N; Stuart, N | 1 |
| Cho, D; Corcoran, E; Dudley, MN; Griffith, DC; Lee, A; Lofland, D; Lomovskaya, O | 1 |
| Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H | 1 |
| Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M | 1 |
| Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM | 1 |
| Craig, M; Cumpston, AD; Devetten, MP; Ericson, SG; Hobbs, GR; Sarwari, AR | 1 |
| Bassett, J; Drusano, GL; Heine, HS; Kinzig-Schippers, M; Louie, A; Miller, L; Sorgel, F; Sullivan, LJ | 1 |
| Fujimoto, Y; Kanbayashi, Y; Matsumoto, Y; Morimoto, Y; Nomura, K; Taniwaki, M | 1 |
| Peters, G; von Eiff, C | 1 |
| Bergogne-Bérézin, E | 1 |
| Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA | 1 |
| Ballone, E; Catamo, G; D'Antonio, D; Di Bonaventura, G; Piccolomini, R | 1 |
| Khaliq, Y; Litzow, MR; Patel, R; Piper, KE; Razonable, RR; Rouse, MS | 1 |
1 review(s) available for levofloxacin and Neutropenia
| Article | Year |
|---|---|
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciprofloxacin; Decision Making; Drug Resistance; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Neoplasms; Neutropenia; Ofloxacin | 2006 |
14 trial(s) available for levofloxacin and Neutropenia
| Article | Year |
|---|---|
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Cohort Studies; Drug Resistance, Microbial; Female; Humans; Induction Chemotherapy; Levofloxacin; Logistic Models; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Allografts; Anti-Bacterial Agents; Bacteremia; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies | 2017 |
Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Female; Humans; Leukemia; Levofloxacin; Male; Neutropenia; Ofloxacin; Single-Blind Method | 2009 |
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Double-Blind Method; Dyspnea; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Leukopenia; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Neutropenia; Ofloxacin; Pain; Taxoids | 2011 |
[A prospective, controlled, non-randomized study of three cohorts to test the effectiveness of two antibiotics levofloxacin and cotrimoxazol on antibacterial prophylaxis in neutropenic patients].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Humans; Leukemia; Levofloxacin; Lymphoma; Middle Aged; Neutropenia; Ofloxacin; Opportunistic Infections; Prospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Digestive System; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Pharynx; Staphylococcus aureus | 2004 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome | 2004 |
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome | 2004 |
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Topics: Amyloidosis; Anemia, Aplastic; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Middle Aged; Multiple Myeloma; Neutropenia; Ofloxacin | 2005 |
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fever of Unknown Origin; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk | 2005 |
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Double-Blind Method; Female; Fever; Hospitalization; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk; Systemic Inflammatory Response Syndrome | 2005 |
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Penicillin V; Treatment Outcome; Viridans Streptococci | 2007 |
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Neutropenia; Ofloxacin; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous | 2007 |
Population pharmacokinetics of levofloxacin as prophylaxis for febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Dose-Response Relationship, Drug; Female; Fever; Humans; Japan; Leukemia; Levofloxacin; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Pilot Projects | 2008 |
26 other study(ies) available for levofloxacin and Neutropenia
| Article | Year |
|---|---|
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Carrier Proteins; Drug Resistance, Microbial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Lactams; Levofloxacin; Membrane Transport Proteins; Mice; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Protein Binding; Pseudomonas aeruginosa; Rats; Sepsis; Serum Albumin; Structure-Activity Relationship | 2003 |
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Bacterial; Humans; Immunocompetence; Levofloxacin; Mice; Microbial Sensitivity Tests; Mutation; Neutropenia; Ofloxacin; Plague; Selection, Genetic; Streptomycin; Thigh; Treatment Outcome; Yersinia pestis | 2007 |
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cyclophosphamide; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Ribosomes; Sepsis; Stereoisomerism; Structure-Activity Relationship; Tetracycline Resistance; Tetracyclines | 2012 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Topics: Anti-Infective Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Neutropenia; Piperacillin; Retrospective Studies; Tazobactam; Transplantation, Homologous | 2023 |
Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fever; Humans; Levofloxacin; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Vincristine; Young Adult | 2020 |
Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies; Transplant Recipients; Young Adult | 2021 |
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies | 2017 |
Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Retrospective Studies | 2019 |
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gastrointestinal Tract; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Neutropenia; Prospective Studies; Risk Factors | 2018 |
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Bacteria; Bacterial Infections; Ciprofloxacin; Female; Fluoroquinolones; Humans; Incidence; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2013 |
The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; beta-Lactam Resistance; Blood; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Molecular Typing; Neutropenia; Prospective Studies; Real-Time Polymerase Chain Reaction; Risk Assessment | 2016 |
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Intensive Care Units; Length of Stay; Levofloxacin; Male; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Respiratory Tract Infections; Risk Factors; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
[Experience accumulated in hospital setting with levofloxacin, in monotherapy and in association therapy].
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hospital Departments; Humans; Levofloxacin; Multicenter Studies as Topic; Neoplasms; Neutropenia; Ofloxacin; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2009 |
Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Fever; Hematologic Neoplasms; Home Infusion Therapy; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Retrospective Studies; Teicoplanin; Treatment Outcome | 2011 |
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Staphylococcus aureus; Stenotrophomonas maltophilia | 2002 |
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Failure | 2004 |
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
Topics: Anemia; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Hematologic Neoplasms; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections | 2004 |
Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy?
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Outer Membrane Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gene Deletion; Genes, Bacterial; Levofloxacin; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Sepsis | 2006 |
Moxifloxacin prophylaxis in neutropenic patients.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines | 2006 |
Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
Topics: Aerosols; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Doxycycline; Female; Gentamicins; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Plague; Protein Biosynthesis; Time Factors; Yersinia pestis | 2007 |
In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Micrococcus; Neutropenia; Ofloxacin | 1998 |
[Resistance and new antibiotic strategies. The other new molecules].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Lactams; Levofloxacin; Neutropenia; Ofloxacin; Peptides; Pneumococcal Infections | 2000 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcaceae | 2001 |
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients.
Topics: Agar; Anti-Infective Agents; Culture Media; Diffusion; Drug Resistance, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Ofloxacin; Staphylococcus | 2002 |
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
Topics: Adult; Aged; Anti-Infective Agents; Bacteremia; Chemoprevention; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcus | 2002 |